No
|
TR-020
|
80-08-0 |
4,4'-Sulfonyldianiline (Dapsone) |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
No
|
TR-020
|
80-08-0 |
4,4'-Sulfonyldianiline (Dapsone) |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
No
|
TR-020
|
80-08-0 |
4,4'-Sulfonyldianiline (Dapsone) |
Rats |
F344/N |
Female |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
Yes
|
TR-020
|
80-08-0 |
4,4'-Sulfonyldianiline (Dapsone) |
Rats |
F344/N |
Male |
Dosed-Feed |
Spleen
|
Positive |
Positive |
(FIBROMA, FIBROSARCOMA, SARCOMA)
|
Neoplastic Lesions
|
No
|
TR-130
|
142-04-1 |
Aniline hydrochloride |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
No
|
TR-130
|
142-04-1 |
Aniline hydrochloride |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
Yes
|
TR-130
|
142-04-1 |
Aniline hydrochloride |
Rats |
F344/N |
Female |
Dosed-Feed |
Spleen
|
Positive |
Positive |
SARCOMA
|
Neoplastic Lesions
|
No
|
TR-130
|
142-04-1 |
Aniline hydrochloride |
Rats |
F344/N |
Male |
Dosed-Feed |
Vascular System (Spleen)
|
Positive |
Positive |
HEMANGIOSARCOMA; SARCOMA OR FIBROSARCOMA
|
Neoplastic Lesions
|
No
|
TR-154
|
103-33-3 |
Azobenzene |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
No
|
TR-154
|
103-33-3 |
Azobenzene |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
Yes
|
TR-154
|
103-33-3 |
Azobenzene |
Rats |
F344/N |
Female |
Dosed-Feed |
Spleen
|
Positive |
Positive |
(FIBROSARCOMA)
|
Neoplastic Lesions
|
Yes
|
TR-154
|
103-33-3 |
Azobenzene |
Rats |
F344/N |
Male |
Dosed-Feed |
Spleen
|
Positive |
Positive |
(SARCOMA, FIBROSARCOMA)
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Rats |
F344/N |
Male |
Inhalation |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
renal tubule, adenoma or carcinoma (2/50, 5/50, 8/50, 7/50)
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Mice |
B6C3F1/N |
Female |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
adenoma (18/50, 23/50, 27/50, 29/50); adenoma or carcinoma (25/50, 26/50, 29/50, 36/50)
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Mice |
B6C3F1/N |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
alveolar/bronchiolar adenoma (1/50, 26/50, 36/50, 38/50); alveolar/bronchiolar carcinoma (3/50, 16/50, 20/50, 34/50); alveolar/bronchiolar adenoma or carcinoma (4/50, 31/50, 42/50, 46/50)
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Mice |
B6C3F1/N |
Male |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
alveolar/bronchiolar adenoma (13/50, 31/50, 31/50, 29/50); alveolar/bronchiolar carcinoma (9/50, 19/50, 32/50, 33/50); alveolar/bronchiolar adenoma or carcinoma (19/50, 38/50, 42/50, 43/50)
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Rats |
F344/N |
Male |
Inhalation |
Nasal Cavity
|
Clear Evidence |
Clear Evidence |
respiratory epithelium, adenoma (0/50, 7/50, 18/49, 10/50)
|
Neoplastic Lesions
|
No
|
TR-542
|
98-82-8 |
Cumene |
Rats |
F344/N |
Female |
Inhalation |
Nasal Cavity
|
Some Evidence |
Some Evidence |
respiratory epithelium, adenoma (0/50, 5/48, 4/50, 3/50)
|
Neoplastic Lesions
|
Yes
|
TR-542
|
98-82-8 |
Cumene |
Mice |
B6C3F1/N |
Male |
Inhalation |
Spleen
|
Clear Evidence |
Equivocal Evidence |
hemangioscaroma
|
May Have Been Related
|
No
|
TR-542
|
98-82-8 |
Cumene |
Rats |
F344/N |
Male |
Inhalation |
Testis
|
Clear Evidence |
Equivocal Evidence |
interstitial cell adenoma
|
May Have Been Related
|
No
|
TR-542
|
98-82-8 |
Cumene |
Mice |
B6C3F1/N |
Male |
Inhalation |
Thyroid Gland Follicular Cell
|
Clear Evidence |
Equivocal Evidence |
adenoma
|
May Have Been Related
|
No
|
TR-225
|
5160-02-1 |
D&C Red No. 9 |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
No
|
TR-225
|
5160-02-1 |
D&C Red No. 9 |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
No
|
TR-225
|
5160-02-1 |
D&C Red No. 9 |
Rats |
F344/N |
Female |
Dosed-Feed |
Liver
|
Equivocal Evidence |
Equivocal |
NEOPLASTIC NODULE 1/50 1/50 5/50
|
Neoplastic Lesions
|
No
|
TR-225
|
5160-02-1 |
D&C Red No. 9 |
Rats |
F344/N |
Male |
Dosed-Feed |
Liver
|
Positive |
Positive |
NEOPLASTIC NODULE 0/50 6/50 7/49
|
Neoplastic Lesions
|
Yes
|
TR-225
|
5160-02-1 |
D&C Red No. 9 |
Rats |
F344/N |
Male |
Dosed-Feed |
Spleen
|
Positive |
Positive |
SARCOMA 0/50 0/50 26/48
|
Neoplastic Lesions
|
No
|
TR-510
|
64-17-5 |
Ethanol |
Mice |
MV |
Female |
Dosed-Water |
Unspecified
|
Inadequate Study |
|
Not applicable
|
Not applicable
|
No
|
TR-510
|
64-17-5 |
Ethanol |
Mice |
MV |
Male |
Dosed-Water |
Unspecified
|
Inadequate Study |
|
Not applicable
|
Not applicable
|
No
|
TR-360
|
121-69-7 |
N,N-Dimethylaniline |
Mice |
B6C3F1 |
Male |
Gavage |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
No
|
TR-360
|
121-69-7 |
N,N-Dimethylaniline |
Rats |
F344/N |
Female |
Gavage |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
No
|
TR-360
|
121-69-7 |
N,N-Dimethylaniline |
Mice |
B6C3F1 |
Female |
Gavage |
Forestomach
|
Equivocal Evidence |
Equivocal Evidence |
SQUAMOUS CELL PAPILLOMA 2/50 2/50 8/50
|
Neoplastic Lesions
|
Yes
|
TR-360
|
121-69-7 |
N,N-Dimethylaniline |
Rats |
F344/N |
Male |
Gavage |
Spleen
|
Some Evidence |
Some Evidence |
SARCOMA 0/49 0/49 3/50 OR OSTEOSARCOMA 0/49 0/49 1/50 COMBINED 0/49 0/49 4/50
|
Neoplastic Lesions
|
No
|
TR-153
|
636-21-5 |
o-Toluidine hydrochloride |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Liver
|
Positive |
Positive |
(ADENOMA OR CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-153
|
636-21-5 |
o-Toluidine hydrochloride |
Rats |
F344/N |
Female |
Dosed-Feed |
Mammary Gland
|
Positive |
Positive |
(ADENOMA OR FIBROADENOMA)
|
Neoplastic Lesions
|
No
|
TR-153
|
636-21-5 |
o-Toluidine hydrochloride |
Rats |
F344/N |
Male |
Dosed-Feed |
Mesothelium (Abdominal Cavity/Tunica Vaginalis)
|
Positive |
Positive |
MESOTHELIOMA
|
Neoplastic Lesions
|
Yes
|
TR-153
|
636-21-5 |
o-Toluidine hydrochloride |
Rats |
F344/N |
Female |
Dosed-Feed |
Spleen
|
Positive |
Positive |
(SARCOMA)
|
Neoplastic Lesions
|
Yes
|
TR-153
|
636-21-5 |
o-Toluidine hydrochloride |
Rats |
F344/N |
Male |
Dosed-Feed |
Spleen
|
Positive |
Positive |
(SARCOMA)
|
Neoplastic Lesions
|
No
|
TR-153
|
636-21-5 |
o-Toluidine hydrochloride |
Rats |
F344/N |
Male |
Dosed-Feed |
Subcutaneous Tissue
|
Positive |
Positive |
(FIBROMA)
|
Neoplastic Lesions
|
No
|
TR-153
|
636-21-5 |
o-Toluidine hydrochloride |
Rats |
F344/N |
Female |
Dosed-Feed |
Urinary Bladder
|
Positive |
Positive |
(TRANSITIONAL CELL CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-153
|
636-21-5 |
o-Toluidine hydrochloride |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Vascular System (Unspecified)
|
Positive |
Positive |
HEMANGIOSARCOMA
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Female |
Gavage |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Male |
Gavage |
Adrenal Gland Medulla
|
Clear Evidence |
Equivocal Evidence |
PHEOCHROMOCYTOMA 13/49 14/48 15/48 26/49
|
May Have Been Related
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Female |
Gavage |
Adrenal Gland Medulla
|
Equivocal Evidence |
Equivocal Evidence |
PHEOCHROMOCYTOMA 2/50 3/50 1/50 6/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Male |
Gavage |
Liver
|
Some Evidence |
Some Evidence |
ADENOMA 9/50 15/49 10/50 44/50 OR CARCINOMA 3/50 7/49 11/50 17/50 COMBINED 11/50 21/49 20/50 21/50
|
Neoplastic Lesions
|
Yes
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Male |
Gavage |
Spleen
|
Clear Evidence |
Clear Evidence |
FIBROSARCOMA 0/49 1/50 2/50 17/50, HEMANGIOSARCOMA 0/49 0/50 0/50 4/50, OR OSTEOSARCOMA 0/49 0/50 1/50 19/50 COMBINED 0/49 1/50 3/50 38/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Female |
Gavage |
Spleen
|
Equivocal Evidence |
Equivocal Evidence |
FIBROSARCOMA 0/50 0/50 1/50 0/50 OR OSTEOSARCOMA 0/50 0/50 0/50 1/50 COMBINED 0/50 0/50 1/50 1/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Male |
Gavage |
Vascular System (Liver)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 2/50 2/50 1/49 6/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Male |
Gavage |
Vascular System (Spleen)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 3/50 2/47 0/49 5/49
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Male |
Dosed-Water |
Forestomach
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA OR SQUAMOUS CELL CARCINOMA 0/46 2/47 3/44 5/45
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Female |
Dosed-Water |
Harderian Gland
|
Clear Evidence |
Clear Evidence |
ADENOMA 3/48 10/48 8/48 21/48 CARCINOMA 0/48 1/48 11/48 11/48 COMBINED 3/48 11/48 19/48 30/48
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Male |
Dosed-Water |
Harderian Gland
|
Clear Evidence |
Clear Evidence |
ADENOMA 3/47 11/47 25/47 28/47 CARCINOMA 0/47 1/47 7/47 16/47 COMBINED 3/47 12/47 30/47 38/47
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Male |
Dosed-Water |
Heart
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 0/48 0/48 1/47 5/48
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Female |
Dosed-Water |
Liver
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 0/48 0/47 1/47 7/47 ADENOMA 5/48 10/47 19/47 18/47 ADENOMA OR CARCINOMA 5/48 11/47 20/47 19/47
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Male |
Dosed-Water |
Liver
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 1/46 2/47 5/46 13/44 ADENOMA 7/46 13/47 17/46 17/44 ADENOMA OR CARCINOMA 12/46 18/47 24/46 23/44
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Female |
Dosed-Water |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 4/48 6/48 17/48 29/47 ALVEOLAR/BRONCHIOLAR CARCINOMA 2/48 4/48 13/48 19/47 COMBINED 6/48 8/48 28/48 39/47
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Male |
Dosed-Water |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 4/48 17/48 22/47 34/48 ALVEOLAR/BRONCHIOLAR CARCINOMA 1/48 1/48 9/47 9/48 COMBINED 5/48 18/48 29/47 37/48
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Female |
Dosed-Water |
Mammary Gland
|
Clear Evidence |
Clear Evidence |
ADENOACANTHOMA 0/47 1/46 1/46 11/48 ADENOCARCINOMA 4/47 3/46 3/46 11/48 COMBINED 4/47 4/46 4/46 22/48
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Female |
Dosed-Water |
Ovary
|
Clear Evidence |
Clear Evidence |
BENIGN GRANULOSA CELL TUMOR 0/48 0/46 2/46 3/39 MALIGNANT GRANULOSA CELL TUMOR 0/48 0/46 0/46 3/39 COMBINED 0/48 0/46 2/46 5/39
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Female |
Dosed-Water |
Skin
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 0/48 0/48 0/46 2/48
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Male |
Dosed-Water |
Skin
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA OR SQUAMOUS CELL CARCINOMA (0/47, 1/48, 5/47, 8/48)
|
Neoplastic Lesions
|
Yes
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Female |
Dosed-Water |
Spleen
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 0/48 0/45 1/47 4/46
|
Neoplastic Lesions
|
No
|
TR-510
|
51-79-6 |
Urethane |
Mice |
MV |
Female |
Dosed-Water |
Uterus/Cervix
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 0/48 0/47 0/48 2/46
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Harderian Gland
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) ADENOMA 4/48 7/48 6/46 20/46 CARCINOMA 1/48 11/48 7/46 10/46 COMBINED 5/48 18/48 13/46 29/46
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Harderian Gland
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) ADENOMA 2/47 3/47 9/46 19/47 CARCINOMA 1/47 3/47 6/46 16/47 COMBINED 3/47 5/47 15/46 35/47
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Harderian Gland
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) ADENOMA 6/48 14/48 21/47 27/48 CARCINOMA 0/48 0/48 1/47 16/48 COMBINED 6/48 14/48 21/47 38/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Harderian Gland
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) ADENOMA 5/47 12/48 15/48 26/45 CARCINOMA 0/47 2/48 2/48 10/45 COMBINED 5/47 14/48 17/48 35/45
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Heart
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 0/47 0/47 0/48 3/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Heart
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) HEMANGIOSARCOMA 0/47 0/48 0/48 6/47
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Heart
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) HEMANGIOSARCOMA 0/47 0/48 1/48 4/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Heart
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 0/48 0/48 2/47 4/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Liver
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 1/47 2/47 0/47 7/46 ADENOMA 6/47 5/47 15/47 23/46 ADENOMA OR CARCINOMA 7/47 5/47 16/47 23/46
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Liver
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) HEMANGIOSARCOMA 0/48 0/47 0/48 6/48 ADENOMA 3/48 6/47 16/48 16/48 ADENOMA OR CARCINOMA 3/48 7/47 16/48 17/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Liver
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) HEMANGIOSARCOMA 2/48 2/46 4/48 13/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Liver
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 3/47 4/48 3/46 11/48 ADENOMA 12/47 15/48 16/46 24/48 ADENOMA OR CARCINOMA 16/47 19/48 17/46 24/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Lung
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) ALVEOLAR/BRONCHIOLAR ADEMONA 5/48 10/48 18/48 30/48 ALVEOLAR/BRONCHIOLAR CARCINOMA 1/48 7/48 9/48 23/48 COMBINED 5/48 17/48 24/48 37/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Lung
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) ALVEOLAR/BRONCHIOLAR ADENOMA 5/47 10/47 16/48 28/48 ALVEOLAR/BRONCHIOLAR CARCINOMA 0/47 2/47 6/48 23/48 COMBINED 5/47 11/47 21/48 38/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Lung
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) ALVEOLAR/BRONCHIOLAR ADEMONA 6/48 8/48 9/48 33/48 ALVEOLAR/BRONCHIOLAR CARCINOMA 5/48 4/48 5/48 17/48 COMBINED 11/48 11/48 14/48 40/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Lung
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) ALVEOLAR/BRONCHIOLAR ADENOMA 10/48 16/48 19/47 35/48 ALVEOLAR/BRONCHIOLAR CARCINOMA 2/48 3/48 8/47 24/48 COMBINED 11/48 19/48 24/47 43/48
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Mammary Gland
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) ADENOACANTHOMA 0/47 0/48 1/48 9/45 ADENOCARCINOMA 3/47 4/48 6/48 15/45 COMBINED 3/47 4/48 7/48 23/45
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Mammary Gland
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) ADENOACANTHOMA 0/47 0/45 2/48 3/47 ADENOCARCINOMA 4/47 3/45 11/48 14/47 COMBINED 4/47 3/45 12/48 16/47
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Ovary
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) BENIGN GRANULOSA CELL TUMOR 0/46 0/47 5/46 3/45 BENIGN OR MALIGNANT GRANULOSA CELL TUMOR 0/46 0/47 6/46 3/45
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Skin
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 0/47 0/47 0/48 2/47
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Skin
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 5% ETHANOL) SQUAMOUS CELL PAPILLOMA OR SQUAMOUS CELL CARCINOMA (0/48, 2/47, 0/48, 7/48)
|
Neoplastic Lesions
|
No
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Skin
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) SQUAMOUS CELL PAPILLOMA OR SQUAMOUS CELL CARCINOMA (0/48, 1/48, 4/46, 7/47)
|
Neoplastic Lesions
|
Yes
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Female |
Dosed-Water |
Spleen
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 0/47 0/46 0/46 3/46
|
Neoplastic Lesions
|
Yes
|
TR-510
|
URETHCOMB |
Urethane + ethanol (combination) |
Mice |
MV |
Male |
Dosed-Water |
Spleen
|
Clear Evidence |
Clear Evidence |
(URETHANE AND 2.5% ETHANOL) HEMANGIOSARCOMA 0/46 0/46 1/46 3/46
|
Neoplastic Lesions
|